Stereotaxis to Report Second Quarter 2020 Financial Results on August 6, 2020

Rhea-AI Summary

Stereotaxis (STXS) announced it will release its financial results for Q2 2020 on August 6, 2020, prior to the U.S. market opening. A conference call will follow at 10:00 a.m. ET to discuss the results and corporate developments. Investors can access the call via phone or webcast. Stereotaxis specializes in robotic technologies for treating cardiac arrhythmias, and its systems are approved in several major markets including the U.S., EU, and Japan.

Positive

• Stereotaxis is positioned as a leader in innovative robotic technologies for arrhythmia treatment.
• The company's systems have received regulatory clearance in key global markets.

Negative

• None.

ST. LOUIS, July 23, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will release financial results for its 2020 second quarter on Thursday, August 6, 2020 before the open of the U.S. financial markets. The Company will host a conference call and webcast at 10:00 a.m. Eastern Time that day to discuss the Company’s results and corporate developments.

100%; border-collapse:collapse !important;">

12%; width:12%; min-width:12%;">What:	88%; width:88%; min-width:88%;">Stereotaxis second quarter financial results conference call
When:	Thursday, August 6, at 10:00 a.m. Eastern Time (7:00 a.m. PT)
Dial In Number:	To access the live call, dial 888-394-8218 (US and Canada) or 786-789-4776 (International) and give the participant pass code 6170258.
Webcast:	To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at http://ir.stereotaxis.com/
Call Replay:	A phone replay of the call will be available for one week beginning approximately two hours following the end of the call through August 13, 2020. To request access for a replay of the conference call, please click here.

About Stereotaxis

Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The core components of Stereotaxis’ systems have received regulatory clearance in the United States, European Union, Japan, Canada, China, and elsewhere. For more information, please visit www.stereotaxis.com.

Company Contacts:
David L. Fischel
Chairman and Chief Executive Officer

Kimberly Peery
Chief Financial Officer

314-678-6100
investors@stereotaxis.com

FAQ

When will Stereotaxis release its Q2 2020 financial results?

Stereotaxis will release its Q2 2020 financial results on August 6, 2020, before the U.S. market opens.

What time is the Stereotaxis Q2 2020 financial results conference call?

The conference call for Stereotaxis' Q2 2020 financial results will be held at 10:00 a.m. ET on August 6, 2020.

How can I access the Stereotaxis Q2 2020 conference call?

You can access the Stereotaxis Q2 2020 conference call by dialing 888-394-8218 (U.S.) or 786-789-4776 (International) with the pass code 6170258.

What is Stereotaxis known for?

Stereotaxis is known for its innovative robotic technologies designed to enhance the treatment of cardiac arrhythmias.